|
|
|
|
| LEADER |
04005nmm a2201117 u 4500 |
| 001 |
EB002166075 |
| 003 |
EBX01000000000000001303854 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841227996
|
| 050 |
|
4 |
|a R857.P6
|
| 100 |
1 |
|
|a Scholz, Carmen
|e [editor]
|
| 245 |
0 |
0 |
|a Tailored polymer architectures for pharmaceutical and biomedical applications
|c Carmen Scholz, editor, University of Alabama in Huntsville, Huntsville, Alabama, Jörg Kressler, editor, Martin Luther University Halle-Wittenberg, Halle, Germany ; sponsored by the ACS Division of Polymer Chemistry, Inc
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 2013, 2013
|
| 300 |
|
|
|a 375 pages
|b illustrations (some color)
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Anti-Bacterial Agents
|
| 653 |
|
|
|a Oligomers / Structure
|
| 653 |
|
|
|a Polyurethanes
|
| 653 |
|
|
|a Block copolymers
|
| 653 |
|
|
|a Drug Design
|
| 653 |
|
|
|a Cellulose / Derivatives
|
| 653 |
|
|
|a Morpholinos
|
| 653 |
|
|
|a Anti-infective agents / Design / Molecular aspects
|
| 653 |
|
|
|a Polyurethanes / Modification
|
| 653 |
|
|
|a Guided tissue regeneration
|
| 653 |
|
|
|a TECHNOLOGY & ENGINEERING / Biomedical / bisacsh
|
| 653 |
|
|
|a Stem cells
|
| 653 |
|
|
|a Peptide antibiotics
|
| 653 |
|
|
|a Stem Cells
|
| 653 |
|
|
|a Lipids / Synthesis
|
| 653 |
|
|
|a Polymers / Therapeutic use
|
| 653 |
|
|
|a Technology, Industry, and Agriculture
|
| 653 |
|
|
|a Macromolecular Substances
|
| 653 |
|
|
|a Polymeric drug delivery systems
|
| 653 |
|
|
|a RNA, Small Interfering
|
| 653 |
|
|
|a Neovascularization, Physiologic
|
| 653 |
|
|
|a Biocompatible Materials
|
| 653 |
|
|
|a Viruses
|
| 653 |
|
|
|a Temperature
|
| 653 |
|
|
|a Neoplasms / therapy
|
| 653 |
|
|
|a Peripheral vascular diseases / Treatment / Technological innovations
|
| 653 |
|
|
|a Peripheral Vascular Diseases / therapy
|
| 653 |
|
|
|a Drugs / Design
|
| 653 |
|
|
|a Polyurethanes / therapeutic use
|
| 653 |
|
|
|a Cellulose / analogs & derivatives
|
| 653 |
|
|
|a Bioconjugates
|
| 653 |
|
|
|a Colloids
|
| 653 |
|
|
|a Glycerin / Modification
|
| 653 |
|
|
|a Biochemical Phenomena
|
| 653 |
|
|
|a Small interfering RNA.
|
| 653 |
|
|
|a Nanomedicine
|
| 653 |
|
|
|a Drug Therapy
|
| 653 |
|
|
|a Nanostructures
|
| 653 |
|
|
|a Thermoresponsive polymers / Health aspects
|
| 653 |
|
|
|a RNA interference
|
| 653 |
|
|
|a Lipids / chemical synthesis
|
| 653 |
|
|
|a Biopolymers
|
| 653 |
|
|
|a Biomedical materials
|
| 653 |
|
|
|a Anti-Infective Agents
|
| 653 |
|
|
|a Neovascularization
|
| 653 |
|
|
|a MEDICAL / Biotechnology / bisacsh
|
| 653 |
|
|
|a Tumors / Treatment
|
| 653 |
|
|
|a Polymers
|
| 653 |
|
|
|a Polymers in medicine
|
| 653 |
|
|
|a HIV Infections / therapy
|
| 653 |
|
|
|a RNA Interference
|
| 653 |
|
|
|a Antineoplastic agents
|
| 653 |
|
|
|a Drug Delivery Systems / methods
|
| 653 |
|
|
|a Biodegradable products
|
| 653 |
|
|
|a Inventions
|
| 653 |
|
|
|a Glycine
|
| 653 |
|
|
|a Therapeutics
|
| 653 |
|
|
|a Antineoplastic Agents
|
| 653 |
|
|
|a Manufactured Materials
|
| 653 |
|
|
|a Peptides
|
| 653 |
|
|
|a Colloids / Health aspects
|
| 653 |
|
|
|a Micelles
|
| 653 |
|
|
|a Drug Delivery Systems
|
| 653 |
|
|
|a Biomedical and Dental Materials
|
| 653 |
|
|
|a Polyurethanes in medicine
|
| 653 |
|
|
|a HIV infections / Treatment / Technological innovations
|
| 653 |
|
|
|a Polymers / chemistry
|
| 653 |
|
|
|a Guided Tissue Regeneration
|
| 653 |
|
|
|a Polymers / therapeutic use
|
| 653 |
|
|
|a Biochemical templates
|
| 653 |
|
|
|a Viruses / Detection / Technological innovations
|
| 700 |
1 |
|
|a Kressler, Jörg
|e [editor]
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Polymer Chemistry
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-2013-1135
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 610.28
|